Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
authFullName_s : B. Pereira

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

A. Buisson , M. Nachury , Mathurin Fumery , T. Guilmoteau , E. Leclerc , et al.
Journal of Crohn's and Colitis, 2022, 16 (1), pp.I120. ⟨10.1093/ecco-jcc/jjab232.115⟩
Article dans une revue hal-03665871v1

Effectiveness of Switching from Intravenous to Subcutaneous Infliximab in Patients with Inflammatory Bowel Diseases: The REMSWITCH Study.

A. Buisson , M. Nachury , M. Reymond , Clara Yzet , P. Wils , et al.
Clinical Gastroenterology and Hepatology, 2022, pp.S1542-3565(22)00776-5. ⟨10.1016/j.cgh.2022.08.011⟩
Article dans une revue hal-03760901v1

Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

A. Buisson , Mathurin Fumery , M. Serrero , L. Orsat , S. Nancey , et al.
2020, pp.S337-S338
Autre publication scientifique hal-03551532v1

Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study

A. Buisson , M. Nachury , M. Reymond , Clara Yzet , P. Wils , et al.
Journal of Crohn's and Colitis, 2022, 16 (1), pp.I393-I394
Article dans une revue hal-03665861v1

French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA)

A. Marques , I. Rieu , B. Pereira , G. Castelnovo , F. Fluchère , et al.
Revue Neurologique, 2023, ⟨10.1016/j.neurol.2023.03.030⟩
Article dans une revue hal-04213230v1